NTLA compared with ARCT: revenue, margins and what each company keeps, and the suppliers and customers both name

NTLAIntellia Therapeutics, Inc.

Mkt capRevenueRevenue

ARCTArcturus Therapeutics Holdings Inc.

Mkt capRevenueRevenue

Compare

NTLAIntellia Therapeutics, Inc.

ARCTArcturus Therapeutics Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 499dMethod ›

Moved together

NTLAwithARCT

×0.39co-movement · ARCT on NTLA · 499d

r 0.41scale to r 0.75

Shared co-movers5with NTLAwith ARCT

BEAMBeam Therapeutics Inc.r 0.63r 0.45

CRSPCRISPR Therapeutics AGr 0.66r 0.43

RXRXRecursion Pharmaceuticals, Inc.r 0.52r 0.41

RGNXRegenxbio Inc.r 0.42r 0.39

EDITEditas Medicine, Inc.r 0.50r 0.38

NTLA, solidARCT, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

NTLAIntellia Therapeutics, Inc.

11.65▼−6.54%· post 11.67

Mkt cap$1.7BRevenue$8MQ2 FY26Revenue$68MFY25

ARCTArcturus Therapeutics Holdings Inc.

9.47▼−14.15%· post 9.47

ClosedNov 2 '26

Mkt cap$269.7MRevenue$3MQ2 FY26Revenue$82MFY25

Compare

ClosedNov 2 '26

NTLAIntellia Therapeutics, Inc.

ARCTArcturus Therapeutics Holdings Inc.

11.65▼−6.54%post 11.67

Price

9.47▼−14.15%post 9.47

$1.7B

Mkt cap

$269.7M

Q2 FY26$8M

Revenue

$3MQ2 FY26

FY25$68M

Revenue

$82MFY25

NTLA11.65▼−6.54%vsARCT9.47▼−14.15%ClosedNov 2 '26